INTERNATIONAL PATENT: DANA-FARBER CANCER INSTITUTE, INC. FILES APPLICATION FOR "A CRYSTALLINE ETHANOLATE OF AN ALLOSTERIC EGFR INHIBITOR AND AN ENANTIOSELECTIVE SYNTHESIS THEREOF"

GENEVA, April 18 -- DANA-FARBER CANCER INSTITUTE, INC. (450 Brookline Ave.Boston, Massachusetts 02215-5450) filed a patent application (PCT/IB2025/060153) for "A CRYSTALLINE ETHANOLATE OF AN ALLOSTERIC EGFR INHIBITOR AND AN ENANTIOSELECTIVE SYNTHESIS THEREOF" on Oct 07, 2025. With publication no. WO/2026/078574, the details related to the patent application was published on Apr 16, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FRYATT, Ross (c/o Dana-Farber Cancer Institute, Inc.450 Brookline Ave.Boston, Massachusetts 02215-5450), GERO, Thomas (c/o Dana-Farber Cancer Institute, Inc.450 Broo...